NO20035204D0 - En PDE4-inhibitor og et anti-cholinergisk middel i kombinasjon for behandling av obstruktive luftveissykdommer - Google Patents

En PDE4-inhibitor og et anti-cholinergisk middel i kombinasjon for behandling av obstruktive luftveissykdommer

Info

Publication number
NO20035204D0
NO20035204D0 NO20035204A NO20035204A NO20035204D0 NO 20035204 D0 NO20035204 D0 NO 20035204D0 NO 20035204 A NO20035204 A NO 20035204A NO 20035204 A NO20035204 A NO 20035204A NO 20035204 D0 NO20035204 D0 NO 20035204D0
Authority
NO
Norway
Prior art keywords
treatment
combination
pde4 inhibitor
obstructive airway
airway diseases
Prior art date
Application number
NO20035204A
Other languages
English (en)
Norwegian (no)
Inventor
John Wesley Watson
Roisin A Armstrong
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129396A external-priority patent/GB0129396D0/en
Priority claimed from GB0210240A external-priority patent/GB0210240D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20035204D0 publication Critical patent/NO20035204D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20035204A 2001-05-25 2003-11-24 En PDE4-inhibitor og et anti-cholinergisk middel i kombinasjon for behandling av obstruktive luftveissykdommer NO20035204D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29360601P 2001-05-25 2001-05-25
GB0129396A GB0129396D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
GB0210240A GB0210240D0 (en) 2002-05-03 2002-05-03 Pharmaceutical combination
PCT/EP2002/005726 WO2002096463A1 (en) 2001-05-25 2002-05-24 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases

Publications (1)

Publication Number Publication Date
NO20035204D0 true NO20035204D0 (no) 2003-11-24

Family

ID=27256347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035204A NO20035204D0 (no) 2001-05-25 2003-11-24 En PDE4-inhibitor og et anti-cholinergisk middel i kombinasjon for behandling av obstruktive luftveissykdommer

Country Status (25)

Country Link
US (1) US20040147544A1 (cs)
EP (1) EP1395288A1 (cs)
JP (1) JP2005508861A (cs)
KR (1) KR20040007605A (cs)
CN (1) CN1511042A (cs)
AP (1) AP2003002909A0 (cs)
BG (1) BG108382A (cs)
BR (1) BR0209992A (cs)
CA (1) CA2446613A1 (cs)
CO (1) CO5640041A2 (cs)
CR (1) CR7152A (cs)
CZ (1) CZ20033150A3 (cs)
EE (1) EE200300585A (cs)
HU (1) HUP0400037A2 (cs)
IL (1) IL158776A0 (cs)
MA (1) MA27027A1 (cs)
MX (1) MXPA03010162A (cs)
NO (1) NO20035204D0 (cs)
NZ (1) NZ529335A (cs)
OA (1) OA12610A (cs)
PA (1) PA8546001A1 (cs)
PL (1) PL367085A1 (cs)
SK (1) SK14312003A3 (cs)
TN (1) TNSN03123A1 (cs)
WO (1) WO2002096463A1 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DK1610787T3 (da) * 2003-03-28 2008-06-02 Nycomed Gmbh Synergistisk kombination der omfatter roflumilast og et antikolinergt middel der er valgt blandt tiotropiumsalte til behandling af respiratoriske sygdomme
WO2004084897A1 (en) * 2003-03-28 2004-10-07 Altana Pharma Ag Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
NZ548300A (en) 2004-02-06 2010-04-30 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
PT1713471E (pt) * 2004-02-06 2012-04-10 Meda Pharma Gmbh & Co Kg Combinação de anticolinérgicos e inibidores de fosfodiesterase tipo 4 para o tratamento de doenças respiratórias
WO2005102344A1 (ja) * 2004-04-27 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
EP1634595B1 (en) * 2004-08-19 2008-08-13 Rottapharm S.p.A. N-Phenylbenzamide derivatives as drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
ES2570332T3 (es) 2005-03-16 2016-05-17 Meda Pharma Gmbh & Co Kg La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
GB0511066D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
KR100696432B1 (ko) * 2005-08-31 2007-03-19 김용환 건강진단용 팬티
US20090054382A1 (en) * 2005-10-19 2009-02-26 Abhijit Ray Compositions of phosphodiesterase type iv inhibitors
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
PT2098248E (pt) 2005-12-21 2012-08-27 Meda Pharma Gmbh & Co Kg Combinação de anticolinérgicos, glucocorticóides e agonistas de beta 2 para o tratamento de doenças inflamatórias
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552407A (en) * 1993-06-11 1996-09-03 New York University Medical Center Anhydroecgonine compounds and their use as anticholinergic agents
DE69525978T2 (de) * 1995-06-06 2002-12-19 Pfizer Trizyclische 5,6-dihydro-9h-pyrazolo(3,4-c)-1,2,4-triazolo(4,3-alpha)pyridine
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors

Also Published As

Publication number Publication date
US20040147544A1 (en) 2004-07-29
AP2003002909A0 (en) 2003-12-31
CZ20033150A3 (cs) 2004-06-16
BG108382A (bg) 2004-12-30
SK14312003A3 (sk) 2004-08-03
KR20040007605A (ko) 2004-01-24
CR7152A (es) 2004-02-23
NZ529335A (en) 2005-09-30
WO2002096463A1 (en) 2002-12-05
PL367085A1 (en) 2005-02-21
CN1511042A (zh) 2004-07-07
EP1395288A1 (en) 2004-03-10
MXPA03010162A (es) 2004-03-10
EE200300585A (et) 2004-04-15
CA2446613A1 (en) 2002-12-05
OA12610A (en) 2006-06-09
TNSN03123A1 (en) 2005-12-23
JP2005508861A (ja) 2005-04-07
PA8546001A1 (es) 2003-12-30
MA27027A1 (fr) 2004-12-20
BR0209992A (pt) 2004-04-06
CO5640041A2 (es) 2006-05-31
HUP0400037A2 (hu) 2004-04-28
IL158776A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
NO20035204D0 (no) En PDE4-inhibitor og et anti-cholinergisk middel i kombinasjon for behandling av obstruktive luftveissykdommer
HUP0402629A3 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
NO20055152D0 (no) Karbonstyrilderivater og humor stabiliserende midler for behandling av humor forstyrrelser
NO20054369D0 (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
EP1524974A4 (en) TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
NO20100477L (no) Anvendelse av risendronat til fremstilling av medikamenter for behandling og prevensjon av osteoporose
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
NO20023566D0 (no) Propionsyrederivater og deres anvendelse ved behandling av sukkkersyke og fedme
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
NO20014648D0 (no) Forbindelser og metoder for behandling av astma, allergi og inflammatoriske sykdommer
NO20034473L (no) Anvendelse av selektive cox-2-inhibitorer ved behandling av urininkontinens
AU2003232148A1 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
IL159379A0 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
NO20052698D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20042389L (no) Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette
EP1482955A4 (en) PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS DISEASES AND OTHER DISEASES USING IMMUNO EFFECTOR COMPOUNDS
NO20043029L (no) Karboksamidinderivater og deres anvendelse ved behandling av vaskulaere sykdommer
EE200300505A (et) Aromataasi inhibiitori kasutamine ravimi valmistamiseks viljatuse raviks
NO20043614L (no) 2`-halogen-3`,5`-dialkoksyfen-1`-yl-imino-2-imidazolid in-derivater og anvendelse derav for behandling av urin-inkontinens
AU2003259689A1 (en) 3-imino-2-indolones for the treatment of depression and/or anxiety
NO20055137D0 (no) Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer
NO20035706D0 (no) Antihistaminer for behandling av nesetetthet og neseobstruksjon
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application